| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 2.018 | 91.954 | 87.291 | 150.306 | 163.360 | 190.914 |
| Total Income - EUR | - | - | - | - | 2.018 | 91.954 | 91.252 | 150.307 | 163.364 | 190.918 |
| Total Expenses - EUR | - | - | - | - | 82 | 68.079 | 78.342 | 173.009 | 135.114 | 182.723 |
| Gross Profit/Loss - EUR | - | - | - | - | 1.936 | 23.875 | 12.910 | -22.702 | 28.250 | 8.196 |
| Net Profit/Loss - EUR | - | - | - | - | 1.876 | 22.955 | 12.141 | -24.198 | 26.616 | 3.221 |
| Employees | - | - | - | - | 0 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Cofocris Biofor S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 0 | 3.617 | 15.431 | 17.727 | 17.035 | 13.117 |
| Current Assets | - | - | - | - | 3.032 | 33.252 | 49.786 | 70.444 | 101.133 | 120.649 |
| Inventories | - | - | - | - | 1.347 | 5.207 | 5.068 | 31.463 | 25.110 | 21.637 |
| Receivables | - | - | - | - | 0 | 1.497 | 3.638 | 30.040 | 66.763 | 94.486 |
| Cash | - | - | - | - | 1.685 | 26.548 | 41.079 | 8.941 | 9.259 | 4.526 |
| Shareholders Funds | - | - | - | - | 1.918 | 24.837 | 36.427 | -5.224 | 21.408 | -1.625 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 1.114 | 12.033 | 28.790 | 93.395 | 96.760 | 135.392 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "1610 - 1610" | |||||||||
| CAEN Financial Year |
1610
|
|||||||||
Comments - Cofocris Biofor S.r.l.